Melinta Therapeutics Announces Appointment of Jisoo Park as Head of Business Development, M&A and Strategy
July 06, 2021 at 08:00 am
Melinta Therapeutics, LLC announces the appointment of Jisoo Park as Head of Business Development, M&A and Strategy, effective July 6, 2021. Jisoo Park joins Melinta under the leadership of President and Chief Executive Officer Christine Ann Miller. Mr. Park joins Melinta from Covis Pharma where he served as Vice President of Business Development and M&A. At Covis, he led global business development and M&A, including transformational buy-side and sell-side M&A, licensing and financings.